|
1. ACC: Retrospective Study Indicates Glitazones
Increase Risk For Heart Failure In
Diabetics
Click
Here
2. Beware of
Meridia
Click Here
3. ITEM
Revisted and UPDATE:
New Amazing Treatment
for Type 2 Diabetes
Click
Here
4. Fasting Glucose Inadequate in Screening for
Cardiovascular Risk
Click Here
5.
Women with Diabetes are Poor and Less
Educated
Click Here
6. Overweight Teens Go to Extremes to Shed
Pounds
Click Here
7. Dietary Fiber,
Glycemic Load, and Risk of Type 2
Diabetes
Click Here
More continued below... |
|
OPEN
STUDIES |
NEW Study #15
WarmFeet® Relaxation
Study
Will use the biofeedback assisted relaxation
training program WarmFeet®, to reduce pain and/or help in improving
wound healing in the feet of a population with limited peripheral
blood flow?
Patient
Benefits: non-invasive; it puts
the patient in charge of his/her well-being; increases blood flow to
the periphery of the body; increases healing; reduces pain;
increases sensory function over time; may lower blood pressure;
non-pharmaceutical and it does not interfere with prescribed
medications.
More information and to learn how
to participate click below: Over 50 educators have signed up more
than 125 patients; if you are interested, act NOW! Click
Here
|
New
CME/CE:
|
|
Joslin
DiabetesFOCUS is a new free 60 minute satellite-delivered or
view on the internet CE broadcast series
targeting issues related to the care of people with diabetes
and its complications.
*
Accredited for physicians, nursing and pharmacy
Join us for the debut of this powerful new
CE series on April 9 when Joslin DiabetesFOCUS presents
"Insulin Management & Intervening
Illness:
Advance
registration is required.
(Click Here) or call 888-466-3250,
ext. 2 for information and to
register
|
|
RELAXATION TRAINING AND ITS
ROLE IN DIABETES AND HEALTH
|
RELAXATION TRAINING AND ITS ROLE IN DIABETES AND
HEALTH
Birgitta I. Rice, M.S., R.Ph., CHES
This series of
articles will provide information on the benefits of relaxation on
health and wellness, with a focus on peripheral circulation
problems in diabetes patients. Click here
 Generate Individualized meal plans for your
patients!
- See how your patients can receive over 250 personalized
recipes that are ideal for individuals with diabetes, high
cholesterol, heart disease and weight management problems. This
revolutionary system instantaneously formulates a nutritionally
and metabolically balance meal plan designed to balance blood
sugar levels, burn unnecessary body fat and increase energy. After
making changes to your meal plan simply push a button to receive
an itemized shopping list.
Click Here For More Information!
|
 Nitric oxide: Results
of a case study with the Anodyne System.
Click Here
|
|
|
The Pharmacy 15 minute Diabetes ConSult
with A1cNow™
A new program for pharmacies to help their
patients with diabetes and generate income by getting
reimbursed for the pharmacist’s knowledge, not just once, but
4 times a year. Click
Here | |
|
This Weeks
Newsletter
March
27,
2002, Issue 97
From the Editors
Desk:
Our
Publisher, Stephen Freed brings you an exclusive
interview with David Kliff, Publisher of Diabetes
Investor. David shares his insights as to the future
of disease management, thru the eyes of Wall Street.
Last year
we broke the news that GLP-1 could
be a major breakthrough for Type 2 diabetes.
This has the potential of changing how we treat diabetes
today. Check
out item #3 a Major Break-Through for Type 2
diabetes. The first time we reported a new study on
GLP-1 was last July, less than a year later there are 4
companies trying to bring a pharmaceutical entity to
market.
Sign up for
the April 9th Joslin Education
program at http://www.diabetesincontrol.com/joslin_full.htm
There is no charge. They are in the process of lining
up remote sites all over the US so call or email them today.
You can also participate at home via the Internet. But you
must be registered to receive the CE/CME. Less than a
week left to register.
Make
sure you check out Dr.
Freedland’s special feature “Why
Focusing On Intensive Glucose Control With Drugs Alone Is
Counterproductive
AADE
scholarship update, 1st RB 305, 2nd JH
237, 3rd CK 185, 4th AP 138,
5th MK 66, We are adding two more gifts.
Check out the medical alert watches http://www.diabetesincontrol.com/medalert.htm
we will be giving away as 6th and 7th
place. So lets get those names in.
Consider making Diabetes in
Control Your home page.
Dave Joffe,
Editor-in-Chief
Steve Freed
Publisher |
| |
|
|
| |
Join Steve, our Publisher, for
a meeting with David Kliff, publisher of the Diabetic
Investor.
Click
Here
|
|
|
| |
Patient Assistance Program
Patient Assistance Program for
your patients that cannot afford their medications. This
program allows them to get their medications for as little as
10 - 20 dollars for a 90 day supply. Click
Here:
|
| |
|
|
| |
Beware of Meridia --
Italy Already Pulled it Off the Market, US
Next?
32 deaths already in Italy
Italy' has
suspended sales of anti-obesity drugs containing sibutramine
after 50 reports of adverse events among people taking the
medicines.
The decision
follows a report from the General Directorate for the
Evaluation of Drugs and Pharmacovigilance. All drugs that
contain sibutramine, including Abbott's anti-obesity drug
Reductil (called Meridia in the US), have been withdrawn from
the market. For complete story and what is
happening in the US. Click
here or go to item #2
|
| |
|
|
| |
 Increasing
Awareness of Type 2 Diabetes in Children:
Is There
A Need?
By Marilyn Porter,
RD, CDE
|
|
|
| |
This
Weeks Corner:
This
Month, Dr. Bernstein is providing us with “What
is CV Exercise” Learn
how to maximize your workouts to get the biggest bang for
your effort!
|
-
Feature Article on
Nutrition |
| |
 Managing
diabetes in "The Golden Years".
Address
some senior-specific issues on
nutrition.
View
Sherri's Archives
By Sherri
Shafer, R.D., CDE, |
-
Dr. Freedland’s special feature
|
| |
|
| |
|
|
| |
Revisited
from July 17, 2001,
Issue 61. See
current update on GLP-1 below, the results will blow you
away. We have come a long way in just 8
months. See
Item #3
Novolog Mix
70/30
Novolog
Mix is an insulin analog premix containing 30%
rapid-acting insulin aspart and 70% that has been
modified into a long-acting formulation. It has been
approved in a subcutaneous injection formulation, for
the control of hyperglycemia. Learn
More, or see
Item #3 Below |
|
| |
|
|
| |
8. Processed Meats Increases Diabetes Risk
Click Here
9. Height may Increase Diabetes
Risk
Click Here
10.
VIAGRA INTERACTS WITH CHOLESTEROL-LOWERING DRUGS
Click Here
11. Repaglinide Best at Mealtimes Three Times a
Day, not Twice
Click Here
12. Long-Term Tight Control of Diabetes is Critical and
Difficult with 50% Not Aware of A1c Goals
Click Here
13. Cases of Blindness Expected to
Double
Click Here
14. Type 2
Diabetes and Hypertriglyceridemic Hyper
ApoB
Click Here
15.
Western Diet
Increases Diabetes Risk
Click Here
Go To TOP
of Page |
|
 Medical Alert™ Watch
is a long overdue alternative to traditional alert
devices. It combines a watch with a medical ID. Excellent for
those who do not like wearing a bracelet or necklace, but want
to identify their medical condition in a time of
emergency……For more information (Click
Here)
©Copyright 2001 Diabetes In
Control
| |
